Compare Mutual Funds
Select a Mutual Fund
Risk | Very High | - |
Rating | 4.0 | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.93 | - |
NAV | ₹38.50 | - |
Fund Started | 12 Nov 2018 | - |
Fund Size | ₹3114.33 Cr | - |
Exit Load | Exit load of 0.50% if redeemed within 1 month. | - |
Risk
Very High
-
Rating
4.0
-
Min SIP Amount
₹100
-
Expense Ratio
1.93
-
NAV
₹38.50
-
Fund Started
12 Nov 2018
-
Fund Size
₹3114.33 Cr
-
Exit Load
Exit load of 0.50% if redeemed within 1 month.
-
1 Year | -4.95% | - |
3 Year | 20.42% | - |
5 Year | 14.48% | - |
1 Year
-4.95%
-
3 Year
20.42%
-
5 Year
14.48%
-
Equity | 98.20% | - |
Cash | 1.80% | - |
Equity
98.20%
-
Cash
1.80%
-
Top 10 Holdings |
| - |
Top 10 Holdings
Cipla Ltd. | 8.69% |
Sun Pharmaceutical Industries Ltd. | 8.48% |
Ipca Laboratories Ltd. | 7.73% |
Globus Medical Inc | 6.78% |
Laurus Labs Ltd. | 6.52% |
Illumina Inc. (USA) | 6.07% |
Sai Life Sciences Ltd. | 5.23% |
Gland Pharma Ltd. | 5.09% |
Cohance Lifesciences Ltd. | 5.04% |
Apollo Hospitals Enterprise Ltd. | 4.40% |
-
Name | - | - |
Start Date | - | - |
Name
-
-
Start Date
-
-
Description | The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. | - |
Launch Date | 12 Nov 2018 | - |
Description
The scheme seeks to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
-
Launch Date
12 Nov 2018
-